NASDAQ
12 hours, 55 minutes ago 
WW
Ww International, INC
8-K: WW International Faces Delisting from Nasdaq Amid Chapter 11 Proceedings
WW International (Weight Watchers) receives notice of delisting from Nasdaq following the commencement of voluntary prepackaged Chapter 11 cases.
Worse than expected
 

NASDAQ
2 days, 23 hours ago 
WW
Ww International, INC
8-K: WW International Files for Chapter 11 to Restructure Debt, Aims for Quick Exit
WW International, Inc. initiates a pre-packaged Chapter 11 reorganization to eliminate $1.15 billion in debt and enhance its financial flexibility.

NASDAQ
3 days, 13 hours ago 
WW
Ww International, INC
10-Q: WW International Faces Debt Restructuring Amidst Financial Challenges
WW International is in discussions to restructure its debt and anticipates a prepackaged bankruptcy filing due to financial difficulties and an expected event of default.
Worse than expected
 

NASDAQ
3 days, 13 hours ago 
WW
Ww International, INC
8-K: WW International Announces Q1 2025 Results, Clinical Subscriptions Surge Amid Debt Restructuring
WW International reports a 9.7% revenue decrease in Q1 2025, but sees a 57.1% increase in clinical subscription revenues and is engaged in discussions for a plan of reorganization to significantly reduce debt.
Worse than expected
 

NASDAQ
18 days, 13 hours ago 
WW
Ww International, INC
DEF: WW International Sets Date for 2025 Annual Shareholder Meeting, Outlines Key Proposals
WW International announces its 2025 Annual Meeting of Shareholders to be held virtually on June 6, 2025, featuring proposals for director elections, auditor ratification, and executive compensation approval.

NASDAQ
21 days, 13 hours ago 
WW
Ww International, INC
Form 4: WW International Executive Michael Amsel Awarded Restricted Stock Units
Chief Marketing Officer Michael Amsel receives 524,109 restricted stock units in WW International, Inc.

NASDAQ
39 days, 13 hours ago 
WW
Ww International, INC
Form 4: WW International CEO Tara Comonte Reports Stock Transactions
Tara Comonte, President and CEO of WW International, reports the acquisition and disposal of common stock and restricted stock units on March 27, 2025.

NASDAQ
49 days, 13 hours ago 
WW
Ww International, INC
8-K: WW International Faces Nasdaq Delisting Notice After Share Price Drops Below $1.00
WW International (WeightWatchers) received a notice from Nasdaq for failing to maintain a minimum share price of $1.00, putting its listing at risk.
Worse than expected
 

NASDAQ
67 days, 12 hours ago 
WW
Ww International, INC
Form 4: WW International CEO Tara Comonte Reports Stock Transactions
Tara Comonte, President and CEO of WW International, reports the acquisition and disposal of common stock and restricted stock units on February 27, 2025.

NASDAQ
70 days, 21 hours ago 
WW
Ww International, INC
10-K: WW International Reports Fiscal Year 2024 Results: Transformation Efforts Continue Amidst Market Challenges
WW International faces revenue decline due to shifts in consumer behavior and increased competition, but focuses on strategic initiatives and cost management.
Worse than expected
 

NASDAQ
71 days, 12 hours ago 
WW
Ww International, INC
8-K: WW International Announces Mixed Q4 and Full Year 2024 Results; Names Tara Comonte Permanent CEO
WW International reports a decrease in overall subscribers and revenue for Q4 and full year 2024, but sees growth in its clinical subscription business and improved margins.
Worse than expected
 

NASDAQ
95 days, 12 hours ago 
WW
Ww International, INC
8-K: WW International Borrows $121.3 Million Under Revolving Credit Facility
WW International draws down the remaining available amount under its senior secured revolving credit facility to enhance financial flexibility.
Worse than expected
 

NASDAQ
100 days, 12 hours ago 
WW
Ww International, INC
Form 4: WW International Interim CEO Tara Comonte Reports Stock Transactions
Tara Comonte, Interim President and CEO of WW International, reports the acquisition and disposal of common stock and restricted stock units on January 27, 2025.

NASDAQ
127 days, 12 hours ago 
WW
Ww International, INC
Form 4: WW International Director William H. Shrank Acquires Deferred Stock Units
Director William H. Shrank acquired 3,696 deferred stock units in WW International, Inc. on December 30, 2024.

NASDAQ
127 days, 12 hours ago 
WW
Ww International, INC
Form 4: WW International Director Acquires Shares Subject to Transfer Restrictions
Tracey D. Brown, a director at WW International, acquired 3,696 shares of common stock subject to transfer restrictions on December 30, 2024.

NASDAQ
127 days, 12 hours ago 
WW
Ww International, INC
Form 4: WW International Director Steven Altschuler Reports Acquisition of Deferred Stock Units
Director Steven Altschuler reported the acquisition of 3,696 deferred stock units in WW International, Inc. on December 30, 2024.

NASDAQ
127 days, 12 hours ago 
WW
Ww International, INC
Form 4: WW International Director Julie J. Rice Acquires Shares
Julie J. Rice, a director at WW International, acquired 3,696 shares of common stock on December 30, 2024.

NASDAQ
127 days, 12 hours ago 
WW
Ww International, INC
Form 4: Thilo Semmelbauer Reports Acquisition of Deferred Stock Units in WW International, Inc.
Director Thilo Semmelbauer acquired 3,696 deferred stock units in WW International, Inc. on December 30, 2024, according to a Form 4 filing.

NASDAQ
127 days, 12 hours ago 
WW
Ww International, INC
Form 4: WW International Director Julie Bornstein Acquires Shares
Director Julie Bornstein acquired 3,696 shares of WW International, Inc. common stock on December 30, 2024.

NASDAQ
127 days, 12 hours ago 
WW
Ww International, INC
Form 4: WW International Director Denis F. Kelly Acquires Deferred Stock Units
Director Denis F. Kelly acquired 3,696 deferred stock units of WW International, Inc. on December 30, 2024.

NASDAQ
129 days, 12 hours ago 
WW
Ww International, INC
Form 4: WW International Executive Tara Comonte Reports Stock Transactions
Tara Comonte, Interim President and CEO of WW International, reports the acquisition and disposal of company stock and restricted stock units.

NASDAQ
158 days, 12 hours ago 
WW
Ww International, INC
Form 4: WW International Interim CEO Tara Comonte Reports Stock Transactions
Interim CEO of WW International, Tara Comonte, reports the acquisition and disposal of company stock and restricted stock units.

NASDAQ
163 days, 21 hours ago 
WW
Ww International, INC
8-K: WW International Announces CFO Transition: Heather Stark Departs, Felicia DellaFortuna Appointed
WW International, Inc. has announced a change in its financial leadership, with Heather Stark stepping down as CFO and Felicia DellaFortuna appointed as her successor.

NASDAQ
171 days, 12 hours ago 
WW
Ww International, INC
Form 4: WW International Corporate Controller Exercises Stock Options and Sells Shares
Nicole Haag, Corporate Controller and Principal Accounting Officer at WW International, exercised stock options and sold a portion of the acquired shares on November 15, 2024.

NASDAQ
171 days, 12 hours ago 
WW
Ww International, INC
Form 4: WW International CFO Exercises Stock Options, Acquires Shares
WW International's Chief Financial Officer, Heather Stark, exercised stock options and acquired 1,758 shares of common stock on November 15, 2024.

NASDAQ
184 days, 12 hours ago 
WW
Ww International, INC
10-Q: WW International Reports Q3 Loss Amidst Restructuring and Impairment Charges
WW International reported a net loss for the third quarter of 2024, impacted by significant impairment charges and restructuring costs, despite a slight increase in gross margin.
Worse than expected
 

NASDAQ
184 days, 21 hours ago 
WW
Ww International, INC
8-K: WW International Reports Mixed Q3 Results Amidst Restructuring and Strategic Shifts
WW International's Q3 2024 results show a decline in overall subscribers and revenue, but a significant increase in clinical subscribers and improved adjusted gross margin.
Worse than expected
 

NASDAQ
192 days, 13 hours ago 
WW
Ww International, INC
Form 4: WW International Interim CEO Tara Comonte Reports Stock Transactions
Interim President and CEO of WW International, Tara Comonte, reports the acquisition and disposal of common stock and restricted stock units on October 27, 2024.

NASDAQ
204 days, 13 hours ago 
WW
Ww International, INC
Form 4: WW International Executive Haag Reports Stock Transactions
Nicole Haag, Corporate Controller and Principal Accounting Officer of WW International, reports the acquisition and disposal of common stock and restricted stock units on October 15, 2024.

NASDAQ
204 days, 13 hours ago 
WW
Ww International, INC
Form 4: WW International CFO Heather Stark Reports Stock Unit Activity
Heather Stark, CFO of WW International, reports the vesting and conversion of restricted stock units into common stock.

WW 
Ww International, INC 
NASDAQ

8-K: WW International Reports Mixed Q3 Results Amidst Restructuring and Strategic Shifts

Sentiment:
 Quarterly Report
 6 November 2024 7:05 AM

WW International's Q3 2024 results show a decline in overall subscribers and revenue, but a significant increase in clinical subscribers and improved adjusted gross margin.

Worse than expected
  The company's revenue and overall subscriber numbers were down compared to the prior year, indicating worse than expected results. 

Summary
  • WW International announced its third quarter 2024 financial results, revealing a mixed performance.
  • Total revenue was $192.9 million, a 10.6% decrease on a constant currency basis compared to the same period last year.
  • Subscription revenue decreased by 6.4% to $191.2 million, while other revenue plummeted by 85.7% due to the discontinuation of the consumer products business.
  • The company experienced an operating loss of $39.0 million, but adjusted operating income was $35.7 million after excluding certain non-cash and restructuring charges.
  • End of period subscribers decreased by 8.8% to 3.7 million, with declines in digital and workshops subscribers, but clinical subscribers increased by 71.5% to 78,000.
  • The company is reiterating its full year 2024 guidance, expecting at least 3.1 million subscribers, $770 million in revenue, and $100 million in adjusted operating income.
Sentiment

Score: 4

Explanation: The sentiment is moderately negative due to the decline in revenue and overall subscribers, despite some positive aspects like the growth in clinical subscribers and improved gross margin. The company faces significant challenges and needs to execute its strategic initiatives effectively.

Highlights
  • Total revenue for Q3 2024 was $192.9 million, a decrease of 10.6% on a constant currency basis compared to the prior year.
  • Subscription revenues decreased by 6.4% to $191.2 million, while other revenues decreased by 85.7% to $1.6 million.
  • End of period subscribers decreased by 8.8% year-over-year to 3.7 million.
  • Clinical subscribers increased by 71.5% to 78,000, while digital subscribers decreased by 7.3% and workshops + digital subscribers decreased by 21.2%.
  • Adjusted gross margin improved to 69.1%, up from 66.2% in the prior year period.
  • The company recorded a non-cash impairment charge of $57.0 million related to franchise rights.
  • Adjusted operating income was $35.7 million, compared to $36.6 million in the prior year period.
  • The company is reiterating its full year 2024 guidance for at least 3.1 million subscribers, $770 million in revenue, and $100 million in adjusted operating income.
Positives
  • Clinical subscriber numbers increased significantly by 71.5% year-over-year.
  • Adjusted gross margin improved to 69.1%, driven by cost reduction initiatives and the discontinuation of the lower-margin consumer products business.
  • The company is on track to deliver on its 2024 adjusted operating income guidance and overall cost savings targets.
  • The company has a cash balance of $57.2 million and no outstanding borrowings under its revolving credit facility.
Negatives
  • Total revenue decreased by 10.6% on a constant currency basis compared to the prior year.
  • Overall subscriber numbers decreased by 8.8% year-over-year, driven by declines in digital and workshops + digital subscribers.
  • Other revenues decreased significantly by 85.7% due to the discontinuation of the consumer products business.
  • The company recorded a $57.0 million non-cash impairment charge related to franchise rights.
  • The company reported an operating loss of $39.0 million, although adjusted operating income was positive at $35.7 million.
Risks
  • The company faces challenges in unifying its solutions and enhancing the member experience.
  • There is a risk of continued decline in digital and workshops + digital subscribers.
  • The company is exposed to risks associated with the rapidly evolving and competitive clinical weight management market.
  • The company's performance is subject to general economic conditions and consumer confidence.
  • The company has a substantial amount of debt and debt service obligations.
Future Outlook

The company is reiterating its full year fiscal 2024 guidance, expecting at least 3.1 million subscribers, $770 million in revenue, and $100 million in adjusted operating income. The company is updating its full year fiscal 2024 operating loss guidance to not exceed $240.4 million.

Management Comments
  • Tara Comonte, Interim CEO, stated that the company is well-equipped to succeed in today's market but has significant work to do to better unify solutions and enhance the member experience.
  • Heather Stark, CFO, noted that cost reduction initiatives continue to yield results, including another quarter of record adjusted gross margin, and that the company remains on track to deliver on its 2024 adjusted operating income guidance and overall cost savings targets.
Industry Context

The results reflect the ongoing challenges in the weight management industry, with a shift towards digital and clinical offerings. The company is facing increased competition and needs to adapt to changing consumer preferences. The decline in traditional workshop subscribers is a trend seen across the industry as consumers move to digital and clinical solutions.

Comparison to Industry Standards
  • WW International's performance is mixed when compared to other players in the weight management industry.
  • While the company's clinical subscriber growth is a positive sign, the overall subscriber decline is concerning when compared to competitors who have seen growth in digital subscriptions.
  • The adjusted gross margin improvement is a positive development, but the revenue decline is a significant challenge.
  • Companies like Noom and Hims & Hers have seen strong growth in digital health and wellness, indicating that WW International needs to accelerate its digital transformation to remain competitive.
  • The impairment charges suggest that WW International may have overvalued some of its assets, which is a concern when compared to more agile and asset-light competitors.
Stakeholder Impact
  • Shareholders may be concerned about the decline in revenue and overall subscribers.
  • Employees may be affected by ongoing restructuring and cost reduction initiatives.
  • Customers may see changes in the company's offerings as it focuses on digital and clinical solutions.
  • Suppliers may be impacted by the discontinuation of the consumer products business.
  • Creditors may be concerned about the company's debt levels and ability to generate sufficient cash flow.
Next Steps
  • The company will continue to focus on cost reduction initiatives.
  • The company will work to unify its solutions and enhance the member experience.
  • The company will continue to develop and expand its clinical offerings.
  • The company will host a conference call to discuss the results and answer questions from the investment community.
Key Dates
  • 2024-09-28: End of the fiscal quarter for which results are reported.
  • 2024-11-06: Date of the press release announcing Q3 2024 financial results and the date of the 8-K filing.
Keywords
WeightWatchers, WW International, weight management, clinical, digital subscriptions, restructuring, financial results, subscribers, revenue, gross margin, operating income, impairment charges

WW 
Ww International, INC 
NASDAQ
Sector: TBD
 
Filings with Classifications
Worse than expected
9 May 2025 5:03 PM

8-K Filing
  • The company received a delisting notice from Nasdaq.
  • The company has commenced voluntary prepackaged cases under chapter 11 of title 11 of the United States Code.
  • Trading of WW International's common stock is expected to be suspended on May 16, 2025.
Worse than expected
6 May 2025 4:13 PM

Quarterly Report
  • The company's financial results were worse than expected due to declining revenues and increasing losses.
  • The company's leverage ratio was worse than required by its debt covenants, leading to an expected event of default.
  • The company's outlook is worse than expected due to the anticipation of a bankruptcy filing.
Worse than expected
6 May 2025 4:03 PM

Earnings Release
  • Overall revenues decreased by 9.7% year-over-year, indicating a decline in the core business.
  • Total subscribers decreased by 14.2% year-over-year, suggesting challenges in retaining and attracting customers.
  • The company is planning a prepackaged filing under Chapter 11 of the U.S. Bankruptcy Code, indicating financial distress.
Worse than expected
21 March 2025 4:05 PM

8-K Filing
  • WW International received a notice from Nasdaq for failing to maintain a minimum share price of $1.00, which is worse than expected.
Worse than expected
28 February 2025 7:14 AM

Annual Results
  • The company's revenue decreased by 11.6% compared to the previous year.
  • The company recorded a net loss of $345.7 million, a significant increase from the net loss of $112.3 million in the previous year.
  • The company's operating loss was $236.2 million, compared to an operating income of $22.3 million in the previous year.
Worse than expected
27 February 2025 4:01 PM

Earnings Release
  • Overall subscriber numbers and total revenues decreased in both Q4 and full year 2024.
  • Digital and Workshops + Digital businesses experienced declines in subscribers and paid weeks.
  • The company reported a significant operating loss for the full year, driven by non-cash impairment charges.
Worse than expected
3 February 2025 4:15 PM

8-K Filing
  • The company needed to draw down the remaining amount of its revolving credit facility, which may indicate financial strain.
Worse than expected
6 November 2024 4:03 PM

Quarterly Report
  • The company's Q3 2024 results were worse than expected due to a significant net loss, a decline in revenue, and substantial impairment charges.
  • The company's net loss for the first nine months of 2024 was significantly worse than the same period in 2023 due to a large impairment charge.
Worse than expected
6 November 2024 7:05 AM

Quarterly Report
  • The company's revenue and overall subscriber numbers were down compared to the prior year, indicating worse than expected results.
Worse than expected
1 August 2024 7:13 AM

Quarterly Report
  • The company's revenue declined by 10.9% in the second quarter and 12.8% for the first six months of 2024, indicating worse than expected performance.
  • The company recorded a significant net loss of $324.6 million for the first six months of 2024, primarily due to a large impairment charge, which is worse than expected.
Worse than expected
1 August 2024 7:05 AM

Quarterly Report
  • The company's revenue decreased by 10.9% year-over-year, indicating worse than expected performance.
  • The company's net income decreased by 54.2% year-over-year, indicating worse than expected performance.
  • The company's total end of period subscribers decreased by 6.1% year-over-year, indicating worse than expected performance.
Worse than expected
24 May 2024 5:15 PM

Amendment to 8-K Filing
  • The proposal to adopt a majority voting standard for uncontested director elections was not approved by shareholders, which is a negative outcome for the company's governance structure.
  • The initial voting results were erroneous, requiring a correction, which reflects poorly on the company's internal processes.
Worse than expected
9 May 2024 5:39 PM

Quarterly Report Amendment
  • The company's net loss of $347.9 million is significantly worse than the $118.7 million loss in the same period last year.
  • The company's revenue decreased by 14.6%, indicating a worse performance compared to the prior year.
  • The company's operating loss of $269.3 million is significantly worse than the $28.6 million loss in the prior year.
Worse than expected
9 May 2024 4:30 PM

Quarterly Report Amendment
  • The company's revenue decreased by 14.6% year-over-year, indicating a worse performance than expected.
  • The company reported a significant operating loss of $269.3 million, primarily due to non-cash impairment charges, which is worse than expected.
  • The company's total end of period subscribers decreased by 0.5% year-over-year, indicating a worse performance than expected.
Worse than expected
2 May 2024 4:09 PM

Quarterly Report
  • The company's net loss of $347.9 million is significantly worse than the $118.7 million loss in the same quarter last year.
  • The company's revenue decreased by 14.6%, indicating a decline in business performance.
  • The company incurred a $258 million impairment charge on franchise rights, further impacting the financial results.
Worse than expected
2 May 2024 4:05 PM

Quarterly Report
  • The company reported a significant operating loss of $269.3 million, primarily due to non-cash impairment charges, which is worse than expected.
  • Subscription revenues decreased by 3.7% on a constant currency basis, indicating a decline in core business performance.
  • Other revenues declined dramatically by 92.0% on a constant currency basis, which is a significant negative impact.
Better than expected
14 March 2024 4:41 PM

Regulation FD Disclosure
  • The company is on track to exceed its previously provided guidance for clinical subscribers, indicating better than expected performance.
Worse than expected
28 February 2024 4:29 PM

Annual Results
  • The company's revenue decreased by 14.5% year-over-year, indicating worse than expected performance.
  • The company's gross profit decreased by 14.8% year-over-year, indicating worse than expected performance.
  • The company's operating income margin decreased by 4.6% year-over-year, indicating worse than expected performance.
Worse than expected
28 February 2024 4:06 PM

Quarterly Report
  • The company's revenue decreased by 7.6% in Q4 2023 and 14.5% for the full year 2023, indicating worse than expected performance.
  • The company reported a net loss of $88.1 million in Q4 2023 and $112.3 million for the full year 2023, which is worse than the prior year.

Disclaimer: This summary was generated by artificial intelligence and its accuracy is not guaranteed. The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.